Does SEMAGLUTIDE Cause Product packaging quantity issue? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Product packaging quantity issue have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 0.2% of all adverse event reports for SEMAGLUTIDE.
94
Reports of Product packaging quantity issue with SEMAGLUTIDE
0.2%
of all SEMAGLUTIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product packaging quantity issue From SEMAGLUTIDE?
Of the 94 reports, 2 (2.1%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Product use in unapproved indication (2,613)
Wrong technique in product usage process (2,538)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which SEMAGLUTIDE Alternatives Have Lower Product packaging quantity issue Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B